When they first came to market for diabetes, they noticed a side effect was weight loss. A potentially complex treatment option The patient side of the equation can be complex, as some experts believe these medications, whether for diabetes or weight loss, may need to be taken throughout a persons life, as a direct treatment or maintenance therapy
Details of the FDA Ruling The FDA's decision, detailed in a March 10, 2025, update, specifies enforcement discretion periods for compounding Semaglutide: For 503A pharmacies (state-licensed), the FDA will not take action for violations related to Semaglutide's shortage list inclusion until April 22, 2025, or until the district court's decision on the preliminary injunction motion in Outsourcing Facilities Association (OFA) v
doi: 10.3390/nu12010157
Abstract Metabolic flexibility describes the ability of cells to respond or adapt its metabolism to support and enable rapid proliferation, continuous growth, and survival in hostile conditions
Type 2 diabetes in adults: management (NG28) NICE